JPMorgan has revised its price target for Clorox (CLX, Financial), reducing it from $173 to $151 while retaining a Neutral rating on the stock. This adjustment comes amid a preview of the beverage, household, and personal care products sector for the first quarter.
The firm highlighted a slowdown in consumer demand, particularly in developed markets such as the United States and Western Europe. This trend is influencing their outlook as they expect investors to become more focused on future guidance rather than immediate earnings outcomes.
Although the sector generally offers a more defensive stance compared to other stocks when it comes to tariffs, some companies within the group are exposed due to sourcing materials from regions heavily affected by trade tensions, especially China.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Clorox Co (CLX, Financial) is $161.48 with a high estimate of $189.00 and a low estimate of $138.00. The average target implies an upside of 14.60% from the current price of $140.90. More detailed estimate data can be found on the Clorox Co (CLX) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Clorox Co's (CLX, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Clorox Co (CLX, Financial) in one year is $148.83, suggesting a upside of 5.63% from the current price of $140.9. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clorox Co (CLX) Summary page.
